3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Conditions
Carcinoma, Non-Small-Cell Lung
14
Prostatic Neoplasms
9
Leukemia, Myeloid, Acute
9
Endometrial Neoplasms
8
Breast Neoplasms
7
Oropharyngeal Neoplasms
5
Neoplasm Metastasis
5
Melanoma
5
Lung Neoplasms
5
Colonic Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
4
Neoplasms
4
Multiple Myeloma
4
Lymphoma, Mantle-Cell
4
Lymphoma, Large B-Cell, Diffuse
4
Leukemia, Myelomonocytic, Acute
4
Leukemia, Monocytic, Acute
4
Leukemia, Megakaryoblastic, Acute
4
Leukemia, Lymphocytic, Chronic, B-Cell
4
Leukemia, Erythroblastic, Acute
4
Congenital Abnormalities
4
Colorectal Neoplasms
4
Stomach Neoplasms
3
Rectal Neoplasms
3
Neuroblastoma
3
Mouth Neoplasms
3
Lymphoma, Follicular
3
Leukemia
3
Esophageal Neoplasms
3
Brain Neoplasms
3
Interventions
Doxorubicin
20
Vincristine
17
Zidovudine
13
Cyclophosphamide
12
Bleomycin
12
Etoposide
10
Rituximab
6
Prednisone
6
Interferon alpha-2
6
Cytarabine
6
Liposomes
5
Filgrastim
5
Dexamethasone
5
tecogalan
4
sargramostim
4
Specimen Handling
4
Methotrexate
4
Magnetic Resonance Spectroscopy
4
Leucovorin
4
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
4
Fluorouracil
4
Biopsy
4
Peripheral Blood Stem Cell Transplantation
3
Paclitaxel
3
Nivolumab
3
interferon alfa-n1
2
fludarabine phosphate
2
fludarabine
2
cabozantinib
2
Whole-Body Irradiation
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
HIV Infections
×
Observation
×
Clear all
NCT02135419
2024-07-26
ANCHOR
AIDS Malignancy Consortium
Phase 3
Completed
4,446 enrolled
13 charts